René van der Merwe

Tezepelumab in Adults with Uncontrolled Asthma

Jonathan Corren, Jane R. Parnes, Wang Liang-wei et al. · New England Journal of Medicine · 2017 · 906 citations · Full text

Asthma, Clinical Immunology, Inflammatory Lung Disease +17

Benralizumab, an anti-interleukin 5 receptor α monoclonal antibody, versus placebo for uncontrolled eosinophilic asthma: a phase 2b randomised dose-ranging study

Mario Castro, Sally E. Wenzel, Eugene R. Bleecker et al. · The Lancet Respiratory Medicine · 2014 · 480 citations

Asthma, Rheumatology, Allergy +10

Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb

Andreas Wollenberg, Michael Howell, Emma Guttman‐Yassky et al. · Journal of Allergy and Clinical Immunology · 2018 · 416 citations

Tezepelumab, an anti–thymic stromal lymphopoietin monoclonal antibody, in the treatment of moderate to severe atopic dermatitis: A randomized phase 2a clinical trial

Eric L. Simpson, Jane R. Parnes, Dewei She et al. · Journal of the American Academy of Dermatology · 2018 · 312 citations · Full text

Benralizumab for chronic obstructive pulmonary disease and sputum eosinophilia: a randomised, double-blind, placebo-controlled, phase 2a study

Christopher E. Brightling, Eugene R. Bleecker, Reynold A. Panettieri et al. · The Lancet Respiratory Medicine · 2014 · 306 citations · Full text

Advanced Lung Disease, Immunology, Clinical Trials +7